GHK-Cu (Copper Peptide)
GHK-Cu (Copper Peptide). Copper-binding tripeptide used topically for skin remodeling.
How it works. Copper carrier that activates fibroblast proliferation and collagen synthesis.
What the research supports. 1 graded claims. Strongest: Topical improves skin elasticity and wound healing (moderate).
How much to take. Typical dose: Topical 0.05–2% serum.
Side effects and interactions. 1 medication interaction listed. No serious side effects listed at normal doses.
Stacking. Pairs well with Collagen peptides, Vitamin C.
Common forms. Available as Topical serum, Injectable (off-label).
Key studies. 8 studies cited. The strongest are listed with links to PubMed.
Community. Experiences from people who have tried GHK-Cu (Copper Peptide). Anecdotes are not medical advice.
GHK-Cu (Copper Peptide). Copper-binding tripeptide used topically for skin remodeling.
What it is
Copper-binding tripeptide used topically for skin remodeling.
Food sources
Goals
How it works
Copper carrier that activates fibroblast proliferation and collagen synthesis.
Pathways
- Collagen synthesis ↑
Effects
- +Skin remodeling supports
What the research supports
Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.
Side effects & interactions
Common side effects
- Skin irritation
Medication interactions
Always disclose GHK-Cu (Copper Peptide) use to your prescriber — additive, antagonistic, or pharmacokinetic interactions are possible.
Check any supplement–medication combination with your pharmacist before starting.
Combines with
Pairs well
- Collagen peptidesProvides amino acid substrate for connective tissue synthesis.
- Vitamin CRequired cofactor for collagen hydroxylation.
Common forms
- Topical serum
- Injectable (off-label)
Key studies
8 studies cited in total.
Opens current human and preclinical literature matching GHK-Cu (Copper Peptide) and "Topical improves skin elasticity and wound healing". Filter by RCT, meta-analysis, or year on the results page.
Opens current human and preclinical literature matching GHK-Cu (Copper Peptide) and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.
Opens current human and preclinical literature matching GHK-Cu (Copper Peptide) and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.
Discussion
Loading discussion…